ReP USP - Resultado da busca

Artigo de periodico
Prognostic value of the immunohistochemical expression of RAD51 and BRCA2 in gastric adenocarcinoma (2022)
Padua, Joel Del Bel; Mariano, Carolline Fontes Alves; Fabro, Alexandre Todorovic; Tirapelli, Daniela Pretti da Cunha; Sankarankutty, Ajith Kumar ; Santos, José Sebastião dos ; Brunaldi, Mariângela Ottoboni
Source: Journal of Histochemistry and Cytochemistry. Unidade: FMRP
Subjects: IMUNOHISTOQUÍMICA, NEOPLASIAS GÁSTRICAS, ESTÔMAGO, ADENOCARCINOMA, ESTUDOS DE COORTES, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PADUA, Joel Del Bel et al. Prognostic value of the immunohistochemical expression of RAD51 and BRCA2 in gastric adenocarcinoma. Journal of Histochemistry and Cytochemistry, v. 70, n. 3, p. 199-210, 2022Tradução . . Disponível em: https://doi.org/10.1369/00221554211065834. Acesso em: 06 nov. 2024.
APA
Padua, J. D. B., Mariano, C. F. A., Fabro, A. T., Tirapelli, D. P. da C., Sankarankutty, A. K., Santos, J. S. dos, & Brunaldi, M. O. (2022). Prognostic value of the immunohistochemical expression of RAD51 and BRCA2 in gastric adenocarcinoma. Journal of Histochemistry and Cytochemistry, 70( 3), 199-210. doi:10.1369/00221554211065834
NLM
Padua JDB, Mariano CFA, Fabro AT, Tirapelli DP da C, Sankarankutty AK, Santos JS dos, Brunaldi MO. Prognostic value of the immunohistochemical expression of RAD51 and BRCA2 in gastric adenocarcinoma [Internet]. Journal of Histochemistry and Cytochemistry. 2022 ; 70( 3): 199-210.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1369/00221554211065834
Vancouver
Padua JDB, Mariano CFA, Fabro AT, Tirapelli DP da C, Sankarankutty AK, Santos JS dos, Brunaldi MO. Prognostic value of the immunohistochemical expression of RAD51 and BRCA2 in gastric adenocarcinoma [Internet]. Journal of Histochemistry and Cytochemistry. 2022 ; 70( 3): 199-210.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1369/00221554211065834
Artigo de periodico
Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics (2022)
Pavan, Marcella; Yamamoto, Priscila; Silva, Rodrigo Moreira da; Salgado Junior, Wilson; Santos, José dos; Kemp, Rafael; Sankarankutty, Ajith Kumar ; Moraes, Natália de; Gaitani, Cristiane de
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: QUIMIOMETRIA, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS, REPRODUTIBILIDADE DE RESULTADOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVAN, Marcella et al. Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics. Journal of Chromatography B, v. 1205, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2022.123338. Acesso em: 06 nov. 2024.
APA
Pavan, M., Yamamoto, P., Silva, R. M. da, Salgado Junior, W., Santos, J. dos, Kemp, R., et al. (2022). Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics. Journal of Chromatography B, 1205. doi:10.1016/j.jchromb.2022.123338
NLM
Pavan M, Yamamoto P, Silva RM da, Salgado Junior W, Santos J dos, Kemp R, Sankarankutty AK, Moraes N de, Gaitani C de. Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics [Internet]. Journal of Chromatography B. 2022 ; 1205[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jchromb.2022.123338
Vancouver
Pavan M, Yamamoto P, Silva RM da, Salgado Junior W, Santos J dos, Kemp R, Sankarankutty AK, Moraes N de, Gaitani C de. Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics [Internet]. Journal of Chromatography B. 2022 ; 1205[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jchromb.2022.123338
Artigo de periodico
Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma (2022)
Barrera, Edwin Cevallos; Martinez, Edson Zangiacomi ; Brunaldi, Mariângela Ottoboni; Donadi, Eduardo Antônio; Sankarankutty, Ajith Kumar ; Kemp, Rafael; Santos, José Sebastião dos
Source: Oncotarget. Unidade: FMRP
Subjects: ADENOCARCINOMA, ESTÔMAGO, NEOPLASIAS, ANÓXIA, ESTUDOS RETROSPECTIVOS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARRERA, Edwin Cevallos et al. Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma. Oncotarget, v. 13, p. 1043-1053, 2022Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.28275. Acesso em: 06 nov. 2024.
APA
Barrera, E. C., Martinez, E. Z., Brunaldi, M. O., Donadi, E. A., Sankarankutty, A. K., Kemp, R., & Santos, J. S. dos. (2022). Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma. Oncotarget, 13, 1043-1053. doi:10.18632/oncotarget.28275
NLM
Barrera EC, Martinez EZ, Brunaldi MO, Donadi EA, Sankarankutty AK, Kemp R, Santos JS dos. Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma [Internet]. Oncotarget. 2022 ; 13 1043-1053.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18632/oncotarget.28275
Vancouver
Barrera EC, Martinez EZ, Brunaldi MO, Donadi EA, Sankarankutty AK, Kemp R, Santos JS dos. Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma [Internet]. Oncotarget. 2022 ; 13 1043-1053.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18632/oncotarget.28275
Artigo de periodico
Clinical outcomes and costs of the use of fibrin sealant in pancreaticojejunal anastomosis after pancreaticoduodenectomy: a retrospective analysis study (2021)
Gaspar, Alberto Facury; Kemp, Rafael; Sankarankutty, Ajith Kumar ; Lopes junior, Jorge Resende; Ferreira Filho, João Almiro; Martone, Daniel; Mota, Gustavo de Assis; Santos, José Sebastião dos
Source: Annals of Medicine and Surgery. Unidade: FMRP
Subjects: PANCREATECTOMIA, FÍSTULA, PÂNCREAS, CUSTOS DOS CUIDADOS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAR, Alberto Facury et al. Clinical outcomes and costs of the use of fibrin sealant in pancreaticojejunal anastomosis after pancreaticoduodenectomy: a retrospective analysis study. Annals of Medicine and Surgery, v. 67, p. 1-5, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.amsu.2021.102531. Acesso em: 06 nov. 2024.
APA
Gaspar, A. F., Kemp, R., Sankarankutty, A. K., Lopes junior, J. R., Ferreira Filho, J. A., Martone, D., et al. (2021). Clinical outcomes and costs of the use of fibrin sealant in pancreaticojejunal anastomosis after pancreaticoduodenectomy: a retrospective analysis study. Annals of Medicine and Surgery, 67, 1-5. doi:10.1016/j.amsu.2021.102531
NLM
Gaspar AF, Kemp R, Sankarankutty AK, Lopes junior JR, Ferreira Filho JA, Martone D, Mota G de A, Santos JS dos. Clinical outcomes and costs of the use of fibrin sealant in pancreaticojejunal anastomosis after pancreaticoduodenectomy: a retrospective analysis study [Internet]. Annals of Medicine and Surgery. 2021 ; 67 1-5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.amsu.2021.102531
Vancouver
Gaspar AF, Kemp R, Sankarankutty AK, Lopes junior JR, Ferreira Filho JA, Martone D, Mota G de A, Santos JS dos. Clinical outcomes and costs of the use of fibrin sealant in pancreaticojejunal anastomosis after pancreaticoduodenectomy: a retrospective analysis study [Internet]. Annals of Medicine and Surgery. 2021 ; 67 1-5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.amsu.2021.102531
Artigo de periodico
The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis (2021)
Vieira, Nivaldo Faria; Serafini, Luciano Neder; Novais, Paulo Cezar; Lizarte Neto, Fermino Sanches; Cirino, Mucio Luiz de Assis; Kemp, Rafael; Ardengh, José Celso; Saggioro, Fabiano Pinto; Gaspar, Alberto Facury; Sankarankutty, Ajith Kumar ; Lopes Júnior, Jorge Resende; Tirapelli, Daniela Pretti da Cunha; Santos, José Sebastião dos
Source: Oncotarget. Unidade: FMRP
Subjects: BIOMARCADORES, NEOPLASIAS PANCREÁTICAS, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Nivaldo Faria et al. The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis. Oncotarget, v. 12, n. 17, p. 1638-1650, 2021Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.28038. Acesso em: 06 nov. 2024.
APA
Vieira, N. F., Serafini, L. N., Novais, P. C., Lizarte Neto, F. S., Cirino, M. L. de A., Kemp, R., et al. (2021). The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis. Oncotarget, 12( 17), 1638-1650. doi:10.18632/oncotarget.28038
NLM
Vieira NF, Serafini LN, Novais PC, Lizarte Neto FS, Cirino ML de A, Kemp R, Ardengh JC, Saggioro FP, Gaspar AF, Sankarankutty AK, Lopes Júnior JR, Tirapelli DP da C, Santos JS dos. The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis [Internet]. Oncotarget. 2021 ; 12( 17): 1638-1650.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18632/oncotarget.28038
Vancouver
Vieira NF, Serafini LN, Novais PC, Lizarte Neto FS, Cirino ML de A, Kemp R, Ardengh JC, Saggioro FP, Gaspar AF, Sankarankutty AK, Lopes Júnior JR, Tirapelli DP da C, Santos JS dos. The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis [Internet]. Oncotarget. 2021 ; 12( 17): 1638-1650.[citado 2024 nov. 06 ] Available from: https://doi.org/10.18632/oncotarget.28038
Artigo de periodico
Is the new procore 20g double forward-bevel needle capable to obtain better histological samples by endoscopic ultrasound for diagnosing solid pancreatic lesions? (2020)
Ardengh, Jose Celso; Brunaldi, Vitor Ottoboni; Brunaldi, Mariângela Ottoboni; Gaspar, Alberto Facury; Lopes Júnior, Jorge Resende; Sankarankutty, Ajith Kumar ; Kemp, Rafael; Santos, José Sebastião dos
Source: ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). Unidades: FMRP, FM
Subjects: ENDOSSONOGRAFIA, NEOPLASIAS PANCREÁTICAS, PATOLOGIA, DIAGNÓSTICO POR IMAGEM, ULTRASSONOGRAFIA, BIÓPSIA POR AGULHA, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARDENGH, Jose Celso et al. Is the new procore 20g double forward-bevel needle capable to obtain better histological samples by endoscopic ultrasound for diagnosing solid pancreatic lesions?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), v. 33, n. 4, p. 1-5, 2020Tradução . . Disponível em: https://doi.org/10.1590/0102-672020200004e1554. Acesso em: 06 nov. 2024.
APA
Ardengh, J. C., Brunaldi, V. O., Brunaldi, M. O., Gaspar, A. F., Lopes Júnior, J. R., Sankarankutty, A. K., et al. (2020). Is the new procore 20g double forward-bevel needle capable to obtain better histological samples by endoscopic ultrasound for diagnosing solid pancreatic lesions? ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 33( 4), 1-5. doi:10.1590/0102-672020200004e1554
NLM
Ardengh JC, Brunaldi VO, Brunaldi MO, Gaspar AF, Lopes Júnior JR, Sankarankutty AK, Kemp R, Santos JS dos. Is the new procore 20g double forward-bevel needle capable to obtain better histological samples by endoscopic ultrasound for diagnosing solid pancreatic lesions? [Internet]. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2020 ; 33( 4): 1-5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1590/0102-672020200004e1554
Vancouver
Ardengh JC, Brunaldi VO, Brunaldi MO, Gaspar AF, Lopes Júnior JR, Sankarankutty AK, Kemp R, Santos JS dos. Is the new procore 20g double forward-bevel needle capable to obtain better histological samples by endoscopic ultrasound for diagnosing solid pancreatic lesions? [Internet]. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2020 ; 33( 4): 1-5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1590/0102-672020200004e1554
Trabalho de evento-resumo periodico
Treatment of cholelithiasis with choledocholithiasis through the association of laparoscopic and endoscopic access, in one-time and outpatient basis, with cost analysis (2020)
Lopes Júnior, Jorge Resende; Orquera, Alicia Guadalupe Mendoza; Gaspar, Alberto Facuri; Lima, Leonardo Santos ; Queiroz, Lucas Tobias Almeida; Kemp, Rafael; Sankarankutty, Ajith Kumar ; Santos, José Sebastião dos
Source: Gastrointestinal Endoscopy. Conference titles: Digestive Disease Week - DDW. Unidade: FMRP
Subjects: COLELITÍASE, SISTEMA GASTROINTESTINAL, ENDOSCOPIA DO SISTEMA DIGESTÓRIO, CIRURGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES JÚNIOR, Jorge Resende et al. Treatment of cholelithiasis with choledocholithiasis through the association of laparoscopic and endoscopic access, in one-time and outpatient basis, with cost analysis. Gastrointestinal Endoscopy. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.gie.2020.03.2383. Acesso em: 06 nov. 2024. , 2020
APA
Lopes Júnior, J. R., Orquera, A. G. M., Gaspar, A. F., Lima, L. S., Queiroz, L. T. A., Kemp, R., et al. (2020). Treatment of cholelithiasis with choledocholithiasis through the association of laparoscopic and endoscopic access, in one-time and outpatient basis, with cost analysis. Gastrointestinal Endoscopy. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.gie.2020.03.2383
NLM
Lopes Júnior JR, Orquera AGM, Gaspar AF, Lima LS, Queiroz LTA, Kemp R, Sankarankutty AK, Santos JS dos. Treatment of cholelithiasis with choledocholithiasis through the association of laparoscopic and endoscopic access, in one-time and outpatient basis, with cost analysis [Internet]. Gastrointestinal Endoscopy. 2020 ; 91( 6): AB369-AB370.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.gie.2020.03.2383
Vancouver
Lopes Júnior JR, Orquera AGM, Gaspar AF, Lima LS, Queiroz LTA, Kemp R, Sankarankutty AK, Santos JS dos. Treatment of cholelithiasis with choledocholithiasis through the association of laparoscopic and endoscopic access, in one-time and outpatient basis, with cost analysis [Internet]. Gastrointestinal Endoscopy. 2020 ; 91( 6): AB369-AB370.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.gie.2020.03.2383
Artigo de periodico
Evaluation of lung function in liver transplant candidates (2018)
Roque, Letícia; Sankarankutty, Ajith Kumar ; Silva Júnior, Orlando de Castro e ; Mente, Ênio David
Source: Transplantation Proceedings. Unidade: FMRP
Subjects: CIRROSE HEPÁTICA, TRANSPLANTE DE FÍGADO, PNEUMOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROQUE, Letícia et al. Evaluation of lung function in liver transplant candidates. Transplantation Proceedings, v. 50, n. 3, p. 762-765, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.transproceed.2018.02.023. Acesso em: 06 nov. 2024.
APA
Roque, L., Sankarankutty, A. K., Silva Júnior, O. de C. e, & Mente, Ê. D. (2018). Evaluation of lung function in liver transplant candidates. Transplantation Proceedings, 50( 3), 762-765. doi:10.1016/j.transproceed.2018.02.023
NLM
Roque L, Sankarankutty AK, Silva Júnior O de C e, Mente ÊD. Evaluation of lung function in liver transplant candidates [Internet]. Transplantation Proceedings. 2018 ; 50( 3): 762-765.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.transproceed.2018.02.023
Vancouver
Roque L, Sankarankutty AK, Silva Júnior O de C e, Mente ÊD. Evaluation of lung function in liver transplant candidates [Internet]. Transplantation Proceedings. 2018 ; 50( 3): 762-765.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.transproceed.2018.02.023
Artigo de periodico
Comprehensive analysis of alternative splicing across tumors from 8,705 patients (2018)
Kahles, André; Lehmann, Kjong-Van; Toussaint, Nora C.; Huser, Matthias; Stark, Stefan G.; Sachsenberg, Timo; Stegle, Oliver; Kohlbacher, Oliver; Sander, Chris; Ratsch, Gunnar; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankuty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cancer Cell. Unidade: FMRP
Subjects: NEOPLASIAS, IMUNOTERAPIA, ANTÍGENOS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAHLES, André et al. Comprehensive analysis of alternative splicing across tumors from 8,705 patients. Cancer Cell, v. 34, n. 2, p. 211–224, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ccell.2018.07.001. Acesso em: 06 nov. 2024.
APA
Kahles, A., Lehmann, K. -V., Toussaint, N. C., Huser, M., Stark, S. G., Sachsenberg, T., et al. (2018). Comprehensive analysis of alternative splicing across tumors from 8,705 patients. Cancer Cell, 34( 2), 211–224. doi:10.1016/j.ccell.2018.07.001
NLM
Kahles A, Lehmann K-V, Toussaint NC, Huser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Ratsch G, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Comprehensive analysis of alternative splicing across tumors from 8,705 patients [Internet]. Cancer Cell. 2018 ; 34( 2): 211–224.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ccell.2018.07.001
Vancouver
Kahles A, Lehmann K-V, Toussaint NC, Huser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Ratsch G, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Comprehensive analysis of alternative splicing across tumors from 8,705 patients [Internet]. Cancer Cell. 2018 ; 34( 2): 211–224.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ccell.2018.07.001
Artigo de periodico
Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines (2018)
Ellrott, Kyle; Bailey, Matthew H.; Saksena, Gordon; Ding, Li; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Systems. Unidade: FMRP
Subjects: MUTAÇÃO GENÉTICA, GENÔMICA, NEOPLASIAS, COMPUTAÇÃO APLICADA, PROJETOS DE PESQUISA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELLROTT, Kyle et al. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Systems, v. 6, n. 3, p. 271-281.e7, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cels.2018.03.002. Acesso em: 06 nov. 2024.
APA
Ellrott, K., Bailey, M. H., Saksena, G., Ding, L., Noushmehr, H., Carlotti Júnior, C. G., et al. (2018). Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Systems, 6( 3), 271-281.e7. doi:10.1016/j.cels.2018.03.002
NLM
Ellrott K, Bailey MH, Saksena G, Ding L, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines [Internet]. Cell Systems. 2018 ; 6( 3): 271-281.e7.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cels.2018.03.002
Vancouver
Ellrott K, Bailey MH, Saksena G, Ding L, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines [Internet]. Cell Systems. 2018 ; 6( 3): 271-281.e7.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cels.2018.03.002
Artigo de periodico
The immune landscape of cancer (2018)
Thorsson, Vésteinn; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Immunity. Unidade: FMRP
Subjects: NEOPLASIAS, CICATRIZAÇÃO, INTERFERONS, MACRÓFAGOS, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
THORSSON, Vésteinn et al. The immune landscape of cancer. Immunity, v. 48, n. 4, p. 812-830.e1-e14, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.immuni.2018.03.023. Acesso em: 06 nov. 2024.
APA
Thorsson, V., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). The immune landscape of cancer. Immunity, 48( 4), 812-830.e1-e14. doi:10.1016/j.immuni.2018.03.023
NLM
Thorsson V, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. The immune landscape of cancer [Internet]. Immunity. 2018 ; 48( 4): 812-830.e1-e14.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.immuni.2018.03.023
Vancouver
Thorsson V, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. The immune landscape of cancer [Internet]. Immunity. 2018 ; 48( 4): 812-830.e1-e14.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.immuni.2018.03.023
Artigo de periodico
Comprehensive characterization of cancer driver genes and mutations (2018)
Bailey, Matthew H.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell. Unidade: FMRP
Subjects: NEOPLASIAS, MUTAÇÃO, GENOMAS, BIOINFORMÁTICA, ENTROPIA, ALGORITMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAILEY, Matthew H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell, v. 173, n. 2, p. 371-385.e1-e9, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2018.02.060. Acesso em: 06 nov. 2024.
APA
Bailey, M. H., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Comprehensive characterization of cancer driver genes and mutations. Cell, 173( 2), 371-385.e1-e9. doi:10.1016/j.cell.2018.02.060
NLM
Bailey MH, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Comprehensive characterization of cancer driver genes and mutations [Internet]. Cell. 2018 ; 173( 2): 371-385.e1-e9.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cell.2018.02.060
Vancouver
Bailey MH, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Comprehensive characterization of cancer driver genes and mutations [Internet]. Cell. 2018 ; 173( 2): 371-385.e1-e9.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cell.2018.02.060
Artigo de periodico
lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer (2018)
Wang, Zehua; Yang, Bob; Zhang, Min; Guo, Weiwei; Wu, Zhiyuan; Wang, Yue; Jia, Lin; Li, Song; Xie, Wen; Yang, Da; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankuty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cancer Cell. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, EPIGÊNESE GENÉTICA, METILAÇÃO DE DNA, CICLO CELULAR, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Zehua et al. lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer. Cancer Cell, v. 33, n. 4, p. 706-720, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ccell.2018.03.006. Acesso em: 06 nov. 2024.
APA
Wang, Z., Yang, B., Zhang, M., Guo, W., Wu, Z., Wang, Y., et al. (2018). lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer. Cancer Cell, 33( 4), 706-720. doi:10.1016/j.ccell.2018.03.006
NLM
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S, Xie W, Yang D, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer [Internet]. Cancer Cell. 2018 ; 33( 4): 706-720.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ccell.2018.03.006
Vancouver
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S, Xie W, Yang D, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer [Internet]. Cancer Cell. 2018 ; 33( 4): 706-720.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ccell.2018.03.006
Artigo de periodico
Oncogenic signaling pathways in the cancer genome atlas (2018)
Sanchez-Vega, Francisco; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell. Unidade: FMRP
Subjects: GENÔMICA, NEOPLASIAS, ONCOLOGIA, TERAPÊUTICA, CICLO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANCHEZ-VEGA, Francisco et al. Oncogenic signaling pathways in the cancer genome atlas. Cell, v. 173, n. 2, p. 321-337.e1-e4, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2018.03.035. Acesso em: 06 nov. 2024.
APA
Sanchez-Vega, F., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Oncogenic signaling pathways in the cancer genome atlas. Cell, 173( 2), 321-337.e1-e4. doi:10.1016/j.cell.2018.03.035
NLM
Sanchez-Vega F, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Oncogenic signaling pathways in the cancer genome atlas [Internet]. Cell. 2018 ; 173( 2): 321-337.e1-e4.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cell.2018.03.035
Vancouver
Sanchez-Vega F, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Oncogenic signaling pathways in the cancer genome atlas [Internet]. Cell. 2018 ; 173( 2): 321-337.e1-e4.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cell.2018.03.035
Artigo de periodico
Machine learning identifies stemness features associated with oncogenic dedifferentiation (2018)
Malta, Tathiane M.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell. Unidade: FMRP
Subjects: GENÔMICA, NEOPLASIAS, CÉLULAS-TRONCO, APRENDIZADO COMPUTACIONAL, ALGORITMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell, v. 173, n. 2, p. 338-354.e1-e5, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2018.03.034. Acesso em: 06 nov. 2024.
APA
Malta, T. M., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell, 173( 2), 338-354.e1-e5. doi:10.1016/j.cell.2018.03.034
NLM
Malta TM, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Machine learning identifies stemness features associated with oncogenic dedifferentiation [Internet]. Cell. 2018 ; 173( 2): 338-354.e1-e5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cell.2018.03.034
Vancouver
Malta TM, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Machine learning identifies stemness features associated with oncogenic dedifferentiation [Internet]. Cell. 2018 ; 173( 2): 338-354.e1-e5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cell.2018.03.034
Artigo de periodico
Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types (2018)
Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankuty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Reports. Unidade: FMRP
Subjects: RNA, MUTAÇÃO, GENOMAS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOUSHMEHR, Houtan et al. Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Reports, v. 23, n. 1, p. 282-296, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2018.01.088. Acesso em: 06 nov. 2024.
APA
Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankuty, A. K., & Tirapelli, D. P. da C. (2018). Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Reports, 23( 1), 282-296. doi:10.1016/j.celrep.2018.01.088
NLM
Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types [Internet]. Cell Reports. 2018 ; 23( 1): 282-296.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.01.088
Vancouver
Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types [Internet]. Cell Reports. 2018 ; 23( 1): 282-296.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.01.088
Artigo de periodico
Comprehensive molecular characterization of the hippo signaling pathway in cancer (2018)
Noushmer, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankuty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Reports. Unidade: FMRP
Subjects: NEOPLASIAS, PROGNÓSTICO, GENES SUPRESSORES DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOUSHMER, Houtan et al. Comprehensive molecular characterization of the hippo signaling pathway in cancer. Cell Reports, v. 25, n. 5, p. 1304-1317, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2018.10.001. Acesso em: 06 nov. 2024.
APA
Noushmer, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankuty, A. K., & Tirapelli, D. P. da C. (2018). Comprehensive molecular characterization of the hippo signaling pathway in cancer. Cell Reports, 25( 5), 1304-1317. doi:10.1016/j.celrep.2018.10.001
NLM
Noushmer H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Comprehensive molecular characterization of the hippo signaling pathway in cancer [Internet]. Cell Reports. 2018 ; 25( 5): 1304-1317.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.10.001
Vancouver
Noushmer H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Comprehensive molecular characterization of the hippo signaling pathway in cancer [Internet]. Cell Reports. 2018 ; 25( 5): 1304-1317.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.10.001
Artigo de periodico
Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas (2018)
Campbell, Joshua D.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Reports. Unidade: FMRP
Subjects: GENÔMICA, CARCINOMA DE CÉLULAS ESCAMOSAS, PROTEÔMICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPBELL, Joshua D. et al. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas. Cell Reports, v. 23, n. 1, p. 194-212.e1-e6, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2018.03.063. Acesso em: 06 nov. 2024.
APA
Campbell, J. D., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas. Cell Reports, 23( 1), 194-212.e1-e6. doi:10.1016/j.celrep.2018.03.063
NLM
Campbell JD, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas [Internet]. Cell Reports. 2018 ; 23( 1): 194-212.e1-e6.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.063
Vancouver
Campbell JD, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas [Internet]. Cell Reports. 2018 ; 23( 1): 194-212.e1-e6.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.063
Artigo de periodico
Driver fusions and their implications in the development and treatment of human cancers (2018)
Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankuty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Reports. Unidade: FMRP
Subjects: RNA, NEOPLASIAS, FUSÃO CELULAR, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOUSHMEHR, Houtan et al. Driver fusions and their implications in the development and treatment of human cancers. Cell Reports, v. 23, n. 1, p. 227-238, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2018.03.050. Acesso em: 06 nov. 2024.
APA
Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankuty, A. K., & Tirapelli, D. P. da C. (2018). Driver fusions and their implications in the development and treatment of human cancers. Cell Reports, 23( 1), 227-238. doi:10.1016/j.celrep.2018.03.050
NLM
Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Driver fusions and their implications in the development and treatment of human cancers [Internet]. Cell Reports. 2018 ; 23( 1): 227-238.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.050
Vancouver
Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Driver fusions and their implications in the development and treatment of human cancers [Internet]. Cell Reports. 2018 ; 23( 1): 227-238.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.050
Artigo de periodico
Systematic analysis of splice-site-creating mutations in cancer (2018)
Jayasinghe, Reyka G.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Reports. Unidade: FMRP
Subjects: RNA, MUTAÇÃO, GENOMAS, NEOPLASIAS, BIOINFORMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAYASINGHE, Reyka G. et al. Systematic analysis of splice-site-creating mutations in cancer. Cell Reports, v. 23, n. 1, p. 270-281.e3, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2018.03.052. Acesso em: 06 nov. 2024.
APA
Jayasinghe, R. G., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Systematic analysis of splice-site-creating mutations in cancer. Cell Reports, 23( 1), 270-281.e3. doi:10.1016/j.celrep.2018.03.052
NLM
Jayasinghe RG, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Systematic analysis of splice-site-creating mutations in cancer [Internet]. Cell Reports. 2018 ; 23( 1): 270-281.e3.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.052
Vancouver
Jayasinghe RG, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Systematic analysis of splice-site-creating mutations in cancer [Internet]. Cell Reports. 2018 ; 23( 1): 270-281.e3.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.052

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration